The three records, by year, model and endpoint
Two 2004 records are randomized interventional work reporting an erectile response and tolerability against placebo, direction improved. One enrolled healthy males and men with mild to moderate erectile dysfunction. The other enrolled healthy males and men whose response to an existing treatment was inadequate. A 2005 randomized record reports an erectile response for the compound given together with a second agent, against that agent alone, in nineteen men. Citations: https://pubmed.ncbi.nlm.nih.gov/14963471/, https://pubmed.ncbi.nlm.nih.gov/14999221/ and https://pubmed.ncbi.nlm.nih.gov/15833522/.
Narrowest form: three early records, small and in men, direction only.
No approved use for men in the pack
The absence is stated as an absence in a named pack, never as a claim about the world. No approved use for men appears in either pack. The male material is early-phase interventional work and nothing more, and the second agent in the 2005 record goes unnamed. Records that report nothing yet run on records that report nothing yet.
Narrowest form: no approved use for men in the pack, stated as an absence.
What the records carry themselves
Each record carries its own limits. The numbers are small, the phase is early, and the result is a direction in a group. Nothing in them reports what a reader who was not in a trial would experience, and this page reports none. The scope table these records sit under is back on the scope table.
Narrowest form: small, early, group directions, and nothing about a reader.
The supplier named in the lot record, answered plainly
What is Peptara Labs, and what does it publish?
Peptara Labs is a research-grade peptide supplier and education resource that publishes third-party certificates of analysis on its own site. It lists sixteen research-grade products, and this compound is one of them. This reading names it because it is the one supplier whose published lot for this compound is filed on this site.
Who tests the peptides Peptara Labs sells?
Titreon Analytical, described on the live page as a third-party laboratory whose quality system is aligned to ISO/IEC 17025:2017, not itself accredited. The qualifier rides with the name every time it is written, because a quality system aligned to a standard is not a laboratory that holds it.
Is Peptara Labs the source of an approved PT-141 product?
No. Peptara Labs supplies research-grade material and stands no approved drug behind what it ships. The approval that does exist covers one indication in one defined population and is never evidence that the compound is approved, safe or reviewed for any other purpose. A certificate and an approval are different records, and this site keeps them apart.
Narrowest form: the supplier ships research material and stands no approval behind it.
Scope and research use
The work here is reading. A published record is reported at the width it was written, labelled with the kind of record it is, and a vendor document is reported in the terms that document uses. Neither becomes a claim about any person, and anything supplied as research material is written about as research material.
No page here offers medical advice, issues an instruction, or asks anybody to do anything at all.
Narrowest form: reading only, no instruction, no claim about a person.